Deignan Charles A.
Officer at Clearside Biomedical, Inc.
- Sold, on record
- $115k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jan 19, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Clearside Biomedical, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Clearside Biomedical, Inc.Plan not statedJun 7, 2016 2016
Sold 2 shares at $7.00 ($14)
Deignan Charles A., Chief Financial Officer
Sold 0% of holdings ($439k position)62,759 shares leftFirst sale on recordFiling
- 2 Form 4 sale Clearside Biomedical, Inc.Plan not statedJun 1, 2020 +1455 days
Sold 14,992 shares at $1.88 ($28k)
Deignan Charles A., Chief Financial Officer
Sold 6.4% of holdings ($443k position)220,827 shares leftFirst sale on recordFiling
- 3 Form 4 sale Clearside Biomedical, Inc.Plan not statedJun 21, 2021 +385 days
Sold 2,938 shares at $4.37 ($13k)
Deignan Charles A., Chief Financial Officer
Sold 0.9% of holdings ($1.4M position)319,249 shares leftFiling
- 4 Form 4 sale Clearside Biomedical, Inc.Plan not statedSep 21, 2021 +92 days
Sold 2,800 shares at $6.41 ($18k)
Deignan Charles A., Chief Financial Officer
Sold 0.9% of holdings ($2M position)316,449 shares leftFiling
- 5 Form 4 sale Clearside Biomedical, Inc.UnusualJan 19, 2022 +120 days
Sold 8,833 shares at $2.09 ($18k)
Deignan Charles A., Chief Financial Officer
Sold 2.5% of holdings ($753k position)351,366 shares left3x usual sizeFiling
- 6 Form 4 sale Clearside Biomedical, Inc.UnusualJan 19, 2023 +365 days
Sold 14,030 shares at $1.50 ($21k)
Deignan Charles A., Chief Financial Officer
Sold 3.7% of holdings ($566k position)363,472 shares left4.8x usual sizeFiling
- 7 Form 144 notice Clearside Biomedical, Inc.NoticeJan 19, 2024 +365 days
Filed to sell 12,900 shares ($17k)
Deignan Charles A., Officer
No 10b5-1 planFiling
- 8 Form 4 sale Clearside Biomedical, Inc.No planJan 19, 2024 same day
Sold 12,900 shares at $1.28 ($17k)
Deignan Charles A., Chief Financial Officer
No 10b5-1 planSold 3.2% of holdings ($509k position)384,662 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Jan 19, 2024 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 12,900 | $17k | 3.2% | No plan | SEC |
| Jan 19, 2024 | Jan 19, 2024 | Clearside Biomedical, Inc. | Officer | Form 144 notice | 12,900 | $17k | Notice | SEC | |
| Jan 19, 2023 | Jan 20, 2023 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 14,030 | $21k | 3.7% | Unusual | SEC |
| Jan 19, 2022 | Jan 20, 2022 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 8,833 | $18k | 2.5% | Unusual | SEC |
| Sep 21, 2021 | Sep 23, 2021 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 2,800 | $18k | 0.9% | Plan not stated | SEC |
| Jun 21, 2021 | Jun 23, 2021 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 2,938 | $13k | 0.9% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 3, 2020 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 14,992 | $28k | 6.4% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 7, 2016 | Clearside Biomedical, Inc. | Chief Financial Officer | Form 4 sale | 2 | $14 | 0.0% | Plan not stated | SEC |